Mutual Non-Disclosure Agreement

Confidentiality for Discovery Discussions

Letterhead

Atlas Power Networks Inc

Draft v1.0

August 13, 2026

Between: Atlas Power Networks Inc ("Atlas")
And: RAD Laboratories ("RAD")
Re: Mutual Non-Disclosure Agreement — Strategic Discovery and Pilot Review

1. Purpose

Scope of mutual confidentiality

Discovery

This Mutual Non-Disclosure Agreement ("Agreement") is entered into to enable confidential discussions between Atlas and RAD regarding a potential strategic discovery engagement, pilot review, and related technical, commercial, and product evaluation.

Each party may disclose confidential information to the other ("Disclosing Party" and "Receiving Party") for the purpose of evaluating a potential business relationship, pilot program, technology integration, investment discussion, or partnership. No obligation to enter into any further agreement is created by this Agreement.

2. Confidential Information

Covered materials

Broad

"Confidential Information" means any and all non-public, proprietary, or sensitive information disclosed by either party, whether in writing, orally, electronically, or by any other means, including but not limited to:

  • Technical data, architecture, source code, algorithms, and system designs
  • Intellectual property, inventions, patents, trade secrets, and know-how
  • Product concepts, roadmaps, specifications, and development plans
  • Commercial terms, pricing, business models, and go-to-market strategies
  • Security practices, audit results, vulnerability assessments, and compliance materials
  • Customer lists, partner relationships, and strategic vendor information
  • Financial projections, funding status, and investor materials
  • Any information marked or identified as "Confidential" or "Proprietary"

3. Obligations

Receiving Party duties

Core
  • Use Confidential Information solely for the purpose of evaluating the potential relationship described herein.
  • Restrict disclosure to employees, advisors, and representatives with a strict need to know, bound by equivalent confidentiality obligations.
  • Protect Confidential Information with at least the same degree of care used to protect its own proprietary information, and in no event less than reasonable care.
  • Not reverse engineer, decompile, or attempt to derive source code or underlying ideas from any disclosed materials.
  • Promptly notify the Disclosing Party of any unauthorized disclosure or breach.

4. Exclusions

Not confidential

Standard
  • Information already publicly available or in the public domain at the time of disclosure.
  • Information already known to the Receiving Party without confidentiality obligations prior to disclosure.
  • Information independently developed by the Receiving Party without use of or reference to the Disclosing Party's Confidential Information.
  • Information rightfully received from a third party without restriction on disclosure.
  • Information required to be disclosed by law, regulation, or court order, provided prompt notice is given to the Disclosing Party.

5. Term

Duration and survival

3–5 Years

This Agreement shall remain in effect for a period of three (3) years from the effective date, unless earlier terminated by mutual written consent. The obligations of confidentiality shall survive termination for a period of five (5) years with respect to general Confidential Information, and indefinitely with respect to trade secrets.

6. No License / No Transfer

IP remains with owner

Critical

Nothing in this Agreement grants either party any license, right, title, or interest in the other party's patents, copyrights, trademarks, trade secrets, or other intellectual property. No transfer of ownership, assignment, or implied license is created by disclosure of Confidential Information.

Each party retains all ownership rights in its pre-existing IP. Any joint IP created during the relationship, if any, would be governed by a separate written agreement.

7. Publicity

No relationship claims

Restricted

Neither party shall issue any press release, public announcement, marketing material, social media post, or other public statement referencing the other party, this Agreement, or the existence of discussions between the parties, without the prior written consent of the other party.

This includes but is not limited to: claims of partnership, endorsement, investment, acquisition, joint venture, or exclusivity. No public reference to the other party's trademarks, brand, or name is permitted without express written consent.

8. Sensitive Data Boundaries

Restricted categories

Conditional

The parties agree that certain categories of information require additional safeguards and explicit agreement before disclosure:

  • Personal data subject to GDPR, CCPA, HIPAA, or other privacy regulations
  • Export-controlled technology or defense-related information
  • Third-party confidential information not owned by the Disclosing Party
  • Customer production data, live system credentials, or network architecture diagrams
  • Source code, models, or datasets not already cleared for external review

Disclosure of any such materials requires prior written consent, a separate data processing agreement where required by law, and confirmation that the Receiving Party's security and compliance posture is adequate.

9. Return and Destruction

Post-termination handling

Standard

Upon termination of this Agreement or upon written request by the Disclosing Party, the Receiving Party shall promptly return or destroy all copies of Confidential Information and certify such return or destruction in writing. The Receiving Party may retain one copy of Confidential Information in its legal or compliance archives, subject to continued confidentiality obligations.

10. Remedies

Injunctive relief

Legal

Each party acknowledges that unauthorized disclosure of Confidential Information may cause irreparable harm for which monetary damages would be inadequate. Each party agrees that the Disclosing Party shall be entitled to seek equitable relief, including injunction and specific performance, in addition to all other remedies available at law or in equity.

Signature Block A

Atlas Power Networks Inc

Pending

Entity: Atlas Power Networks Inc

Authorized Signatory: Robert Smith, President/CEO

Email: info@atlaspower.ai

Date: _______________

Signature

Signature Block B

RAD Laboratories

Pending

Entity: RAD Laboratories

Authorized Signatory: _______________

Email: _______________

Date: _______________

Signature

Disclaimer

Counsel review required

Non-legal

This document is a draft template prepared for discussion purposes only. It does not constitute legal advice, a binding agreement, or a substitute for qualified legal counsel. Atlas Power Networks Inc does not provide legal opinions, patent opinions, or freedom-to-operate opinions. Both parties are strongly encouraged to have this draft reviewed by their respective qualified legal counsel before execution.

Prepared as a private strategic discovery concept for RAD Laboratories by Atlas Power Networks Inc. Based on public and conversational materials only. No partnership, endorsement, or signed agreement is claimed.